FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4312117595> ?p ?o ?g. }

• W4312117595 endingPage "6673" @default.
• W4312117595 startingPage "6655" @default.
• W4312117595 abstract "Chondrosarcomas (CHSs), which represent 20% of primary bone tumors in adults, are mostly resistant to radio- and chemotherapy. It is therefore essential that new therapeutic approaches, targeted to the tumour, be developed to improve the prognosis of patients. The effectiveness, as a radiosensitizing agent, of gadolinium oxide nanoparticles (GdoNP, AGuIX®) nanoparticles in CHS was evaluated in vitro, in spheroid CHS models allowing to reproduce cell-cell extracellular matrix interactions, and, in vivo, in a nude mouse model with heterotopic tumour xenograft.Spheroids from SW1353 and HEMC-SS cells were characterized by confocal microscopy with or without GdoNP treatment. Real-time microscopy enabled quantification of cell viability, cell migration and invasion. In vivo, the efficacy of the association of GdoNP combined with a single (4Gy) or fractionated (4x1Gy) irradiation was evaluated in HEMC-SS tumor-bearing mice by monitoring tumor growth, mouse survival and gene expression profile.The expression of proteoglycans in the extra-cellular matrix (ECM) of spheroids demonstrated the relevance of the 3-D model. The combination of GdoNP with single or fractionated irradiation increased the lethal effects of irradiation on 2-D- and 3-D-cultured cells. In vivo, a single or a fractionated dose of 4 Gy associated with IT or IV injection of GdoNP decreased tumor growth significantly. Only IT injection increased mice survival. Unexpectedly, the radiosensitizing effect of GdoNP was associated, in vitro, with a significant decrease in invasion-migration capacities and, in vivo, with the decreased expression of PTX3, a protein involved in the epithelial-to-mesenchymal transition process, suggesting a potential impact of GdoNP on metastasis formation.These results provide the first proof of concept of the radiosensitizing effect of GdoNP in CHSs and opened the way for a multicentre, randomized Phase 2 trial evaluating the association of GdoNP with radiotherapy for the therapeutic management of patients with symptomatic inoperable musculoskeletal tumor lesions." @default.
• W4312117595 created "2023-01-04" @default.
• W4312117595 creator A5000170394 @default.
• W4312117595 creator A5001956141 @default.
• W4312117595 creator A5003870521 @default.
• W4312117595 creator A5005068161 @default.
• W4312117595 creator A5026061623 @default.
• W4312117595 creator A5030533603 @default.
• W4312117595 creator A5043706856 @default.
• W4312117595 creator A5060484425 @default.
• W4312117595 creator A5063724494 @default.
• W4312117595 creator A5075051856 @default.
• W4312117595 creator A5085361216 @default.
• W4312117595 creator A5088659264 @default.
• W4312117595 date "2022-12-01" @default.
• W4312117595 modified "2023-10-02" @default.
• W4312117595 title "Proof of Concept of the Radiosensitizing Effect of Gadolinium Oxide Nanoparticles in Cell Spheroids and a Tumor-Implanted Murine Model of Chondrosarcoma" @default.
• W4312117595 cites W1700608000 @default.
• W4312117595 cites W1969686625 @default.
• W4312117595 cites W1994137424 @default.
• W4312117595 cites W2007455209 @default.
• W4312117595 cites W2012389751 @default.
• W4312117595 cites W2096456517 @default.
• W4312117595 cites W2098217042 @default.
• W4312117595 cites W2115368512 @default.
• W4312117595 cites W2131665195 @default.
• W4312117595 cites W2146804964 @default.
• W4312117595 cites W2150312029 @default.
• W4312117595 cites W2204695292 @default.
• W4312117595 cites W2279343446 @default.
• W4312117595 cites W2346871801 @default.
• W4312117595 cites W2390782195 @default.
• W4312117595 cites W2470057209 @default.
• W4312117595 cites W2486254046 @default.
• W4312117595 cites W2517794445 @default.
• W4312117595 cites W2583071500 @default.
• W4312117595 cites W2589405746 @default.
• W4312117595 cites W2735181486 @default.
• W4312117595 cites W2737276581 @default.
• W4312117595 cites W2742960581 @default.
• W4312117595 cites W2768980517 @default.
• W4312117595 cites W2769613211 @default.
• W4312117595 cites W2791751637 @default.
• W4312117595 cites W2793590116 @default.
• W4312117595 cites W2837455999 @default.
• W4312117595 cites W2889461012 @default.
• W4312117595 cites W2889918489 @default.
• W4312117595 cites W2891363625 @default.
• W4312117595 cites W2905148884 @default.
• W4312117595 cites W2913659774 @default.
• W4312117595 cites W2913906966 @default.
• W4312117595 cites W2947402976 @default.
• W4312117595 cites W2947660198 @default.
• W4312117595 cites W2953601937 @default.
• W4312117595 cites W2961319233 @default.
• W4312117595 cites W2968896536 @default.
• W4312117595 cites W2979620506 @default.
• W4312117595 cites W2991465574 @default.
• W4312117595 cites W3000296117 @default.
• W4312117595 cites W3004261179 @default.
• W4312117595 cites W3007323650 @default.
• W4312117595 cites W3008761832 @default.
• W4312117595 cites W3043329409 @default.
• W4312117595 cites W3095337093 @default.
• W4312117595 cites W3159142974 @default.
• W4312117595 doi "https://doi.org/10.2147/ijn.s390056" @default.
• W4312117595 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36582458" @default.
• W4312117595 hasPublicationYear "2022" @default.
• W4312117595 type Work @default.
• W4312117595 citedByCount "2" @default.
• W4312117595 countsByYear W43121175952023 @default.
• W4312117595 crossrefType "journal-article" @default.
• W4312117595 hasAuthorship W4312117595A5000170394 @default.
• W4312117595 hasAuthorship W4312117595A5001956141 @default.
• W4312117595 hasAuthorship W4312117595A5003870521 @default.
• W4312117595 hasAuthorship W4312117595A5005068161 @default.
• W4312117595 hasAuthorship W4312117595A5026061623 @default.
• W4312117595 hasAuthorship W4312117595A5030533603 @default.
• W4312117595 hasAuthorship W4312117595A5043706856 @default.
• W4312117595 hasAuthorship W4312117595A5060484425 @default.
• W4312117595 hasAuthorship W4312117595A5063724494 @default.
• W4312117595 hasAuthorship W4312117595A5075051856 @default.
• W4312117595 hasAuthorship W4312117595A5085361216 @default.
• W4312117595 hasAuthorship W4312117595A5088659264 @default.
• W4312117595 hasBestOaLocation W43121175951 @default.
• W4312117595 hasConcept C142724271 @default.
• W4312117595 hasConcept C1491633281 @default.
• W4312117595 hasConcept C150903083 @default.
• W4312117595 hasConcept C175369904 @default.
• W4312117595 hasConcept C185592680 @default.
• W4312117595 hasConcept C189165786 @default.
• W4312117595 hasConcept C202751555 @default.
• W4312117595 hasConcept C207001950 @default.
• W4312117595 hasConcept C2776302905 @default.
• W4312117595 hasConcept C502942594 @default.
• W4312117595 hasConcept C55493867 @default.
• W4312117595 hasConcept C71924100 @default.
• W4312117595 hasConcept C86803240 @default.

• next